MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Retinal thickness as a marker of disease progression in progressive supranuclear palsy

    Y. Chen, H. Wang, B. Wang, B. Li, P. Ye, W. Xu, P. Liu, X. Chen, Z. Cen, Z. Ouyang, S. Wu, X. Dou, Y. Liao, W. Luo (Hangzhou, China)

    Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…
  • 2022 International Congress

    CCDC88C p.R464H likely cause a novel late-onset parkinsonism phenotype

    Z. Lin, W. Luo (Hangzhou, China)

    Objective: We describe two sisters with late-onset parkinsonism associated with a CCDC88C variant (p.R464H). Background: Tsoi et al. (2014) identified a heterozygous missense mutation in the CCDC88C gene (R464H), by…
  • 2022 International Congress

    Multi-modal MRI features and their relationship with clinical scales in Parkinson disease and Atypical Parkinsonian Syndromes

    H. Martinez-Hernandez, D. Lopez-Mena, B. Candela-Solano, A. Medina-Islas, L. Alvarez, I. Acosta (Mexico City, Mexico)

    Objective: To compare MRI sings and volumetric measurements in Parkinson disease (PD), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA) and their relationship with…
  • 2022 International Congress

    Mutational effects of LRRK2 I1371V in astrocytes derived from patient specific iPSCs

    R. Banerjee, I. Datta, S. Jagtap, A. Raj (Bangalore, India)

    Objective: To identify the LRRK2 I1371V mutational effects on astroglial biology involving glutamate metabolism and glutathione machinery. Background: The underlying cause of most of the familial…
  • 2022 International Congress

    Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease

    GBY. Babacan-Yildiz, CZK. Kayacan, IK. Karacan, BS. Sumbul, BE. Elibol, OG. Gelisin, OA. Akgul (ISTANBUL, Turkey)

    Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and  the potential effect of gut microbiota on pre-motor…
  • 2022 International Congress

    Availability and accessibility of medicines for patients with Parkinson’s disease in Kyrgyzstan

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study was to assess the availability and accessibility of medicines for patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: After…
  • 2022 International Congress

    Level of glial neurotrophic factor in the blood plasma depending on the duration of Parkinson’s disease

    B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic factor in the blood plasma depending on the duration of PD. Background: Study of the biochemical aspects…
  • 2022 International Congress

    Exosomes from human dental pulp stem cells as a cell-free drug delivery vehicle in vitro and in vivo chronic PD rat model through the intranasal route targeting efficacy & bio-distribution.

    I. Datta, A. Kaushal, K. Mondal (Bangalore, India)

    Objective: To evaluate the drug encasement in human dental pulp stem cell derived exosomes and its delivery in vitro in single cell level using fluorescence…
  • 2022 International Congress

    Chorea Hyperglycemic Basal Ganglia syndrome(CHBG) with Diabetic Lumbosacral Radiculoplexus Neuropathy – A rare case presentation

    S. Pandey, M. Varma, C. Gaba, S. Jain, A. Goswami (New Delhi, India)

    Objective: To demonstrate that metabolic derangement can lead to choreiform  movement disorder. Background: Hemichorea  are involuntary, non-patterned movement disorders caused by lesions of the contralateral…
  • 2022 International Congress

    Evaluation of α-synuclein pathology and function in dopaminergic neurons derived from LRRK2 I1371V PD patient iPSCs

    I. Datta, S. Jagtap, C. Potdar (Bangalore, India)

    Objective: To evaluate cellular pathogenesis in DA neuron function, and α-synuclein pathology using LRRK2-I1371V PD iPSC. Background: It is reported for complex-neurodegenerative disorders like PD,…
  • « Previous Page
  • 1
  • …
  • 825
  • 826
  • 827
  • 828
  • 829
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley